FBX 40 Tablet contains Febuxostat 40mg, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, FBX 40 reduces the production of uric acid in the body, thereby preventing the formation of urate crystals that cause painful gout attacks and joint inflammation. This medication is indicated for long-term treatment to maintain lower serum uric acid levels, helping to reduce the frequency of acute gout flares and improve patient quality of life. FBX 40 is typically prescribed when patients are intolerant to or inadequately managed by other urate-lowering therapies such as allopurinol. It is important to take FBX 40 exactly as directed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any history of cardiovascular disease, liver or kidney problems before starting treatment. Common side effects may include nausea, rash, or liver enzyme abnormalities, and regular monitoring of liver function tests is recommended during therapy. FBX 40 should be used cautiously in combination with other medications that affect uric acid levels. Always consult a healthcare provider for personalized advice and before discontinuing the medication.